U.S. Markets open in 9 hrs 9 mins
  • S&P Futures

    3,451.25
    +2.00 (+0.06%)
     
  • Dow Futures

    28,280.00
    +12.00 (+0.04%)
     
  • Nasdaq Futures

    11,669.00
    +19.25 (+0.17%)
     
  • Russell 2000 Futures

    1,631.80
    +1.20 (+0.07%)
     
  • Crude Oil

    40.61
    -0.03 (-0.07%)
     
  • Gold

    1,908.10
    +3.50 (+0.18%)
     
  • Silver

    24.74
    +0.03 (+0.13%)
     
  • EUR/USD

    1.1801
    -0.0025 (-0.2124%)
     
  • 10-Yr Bond

    0.8480
    +0.0320 (+3.92%)
     
  • Vix

    28.11
    -0.54 (-1.88%)
     
  • GBP/USD

    1.3064
    -0.0016 (-0.1241%)
     
  • USD/JPY

    104.7100
    -0.1300 (-0.1240%)
     
  • BTC-USD

    12,952.88
    +47.89 (+0.37%)
     
  • CMC Crypto 200

    261.17
    +5.07 (+1.98%)
     
  • FTSE 100

    5,785.65
    +9.15 (+0.16%)
     
  • Nikkei 225

    23,557.19
    +82.92 (+0.35%)
     

PolarityTE to Attend the Oppenheimer 30th Annual Healthcare Conference

·1 min read

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today that it will attend the Oppenheimer 30th Annual Healthcare Conference held on March 17-18, 2020 in New York, NY.

A live audio webcast of the Oppenheimer 30th Annual Conference presentation on March 17, 2020 at 11:30am ET will be accessible in real time on the "News & Media/Events" section of PolarityTE's website at www.polarityte.com/news-media/events or via the following link:

Link to Webcast

About PolarityTE®

PolarityTE is focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures products from the patient's own tissue and uses the patient's own body to support the regenerative process. From a small piece of healthy autologous tissue, the company creates a dynamic and self-propagating product designed to regenerate the target tissues. PolarityTE's innovative method is intended to promote and accelerate growth of the patient's tissues to undergo a form of effective regenerative healing. Learn more at www.PolarityTE.com – Welcome to the Shift®.

POLARITYTE, the POLARITYTE logo, WHERE SELF REGENERATES SELF, WELCOME TO THE SHIFT, and SKINTE are trademarks or registered trademarks of PolarityTE, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200305005134/en/

Contacts

Investors:
Rich Haerle
VP, Investor Relations
PolarityTE, Inc.
ir@PolarityTE.com
(385) 315-0697

Media:
Angela Ziegler
VP, Marketing and Public Relations
PolarityTE, Inc.
AngelaZiegler@PolarityTE.com
(385) 239-0363